Efficacy of zinc–carnosine chelate compound, Polaprezinc, enemas in patients with ulcerative colitis

References

• Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182–205.
   PubMed Web of Science ®Google Scholar
• Macdermott RP, Green JA. Refractory ulcerative colitis treatment. Gastroenterol Hepatol (N Y) 2007;3:64–9.
   PubMedGoogle Scholar
• Grønbæk H, Vestergaard EM, Hey H, Nielsen JN, Nexø E. Serum trefoil factors in patients with inflammatory bowel disease. Digestion 2006;74:33–9.
   PubMed Web of Science ®Google Scholar
• Ido A, Numata M, Kodama M, Tsubouchi H. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J Gastroenterol 2005;40:925–31.
   PubMed Web of Science ®Google Scholar
• Ito M, Tanaka T, Suzuki Y. Effect of N-(3-aminopropionyl)-L-histidinato zinc (Z-103) on healing and hydrocortisone-induced relapse of acetic acid ulcers in rats with limited food-intake-time. Jpn J Pharmacol 1990;52:513–20.
   PubMedGoogle Scholar
• Arakawa T, Satoh H, Nakamura A, Nebiki H, Fukuda T, Sakuma H, et al. Effects of zinc-carnosine on gastric mucosal and cell damage caused by ethanol in rats. Correlation with endogenous prostaglandin E2. Dig Dis Sci 1990;35:559–66.
   PubMed Web of Science ®Google Scholar
• Kato S, Nishikawa H, Konaka A, Takeuchi K. Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate. Dig Dis Sci 1997;42:2156–63.
   PubMed Web of Science ®Google Scholar
• Solomons NW, Rosenberg IH, Sandstead HH, Vo-Khactu KP. Zinc deficiency in Crohn's disease. Digestion 1977;16:87–95.
   PubMed Web of Science ®Google Scholar
• Naber TH, van den Hamer CJ, Baadenhuysen H, Jansen JB. The value of methods to determine zinc deficiency in patients with Crohn's disease. Scand J Gastroenterol 1998;33:514–23.
   PubMed Web of Science ®Google Scholar
• Schoelmerich J, Becher MS, Hoppe-Seyler P, Matern S, Haeussinger D, Loehle E, et al. Zinc and vitamin A deficiency in patients with Crohn's disease is correlated with activity but not with localization or extent of the disease. Hepatogastroenterology 1985;32:34–8.
   PubMedGoogle Scholar
• Seiki M, Ueki S, Tanaka Y, Soeda M, Hori Y, Aita H, et al. Studies on anti-ulcer effects of a new compound, zinc L-carnosine (Z-103). Folia Pharmacol Jpn 1990;95:257–69.
   PubMed Web of Science ®Google Scholar
• Fujii Y, Matsuura T, Kai M, Kawasaki H, Yamada K. Protection by polaprezinc, an anti-ulcer drug, against indomethacin-induced apotosis in gastric mucosal cells. Jpn J Pharmacol 2000;84:63–70.
   PubMedGoogle Scholar
• Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, Kondo M. The antioxidant properties of a novel zinc-carnosine chelate compound, N-(3-aminopropionyl)-L-histidinato zinc. Biochim Biophys Acta 1991;1115:15–22.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, Yasuda M, Ueda S, et al. Effect of Zinc-carnosine chelate compound (Z-103), a novel antioxidant, on acute gastric mucosal injury induced by ischemia-reperfusion in rats. Free Rad Res Commun 1991;14:289–96.
   PubMed Web of Science ®Google Scholar
• Cho CH, Luk CT, Ogle CW. The membrane-stabilizing action of zinc carnosine (Z-103) in stress-induced gastric ulceration in rats. Life Sci 1991;49:189–94.
   Web of Science ®Google Scholar
• Odashima M, Otaka M, Jin M, Konishi N, Sato T, Kato S, et al. Induction of a 72-kDa heat shock protein in cultured rat gastric mucosal cells and rat gastric mucosa by zinc L-carnosine. Dig Dis Sci 2002;47:2799–804.
   PubMed Web of Science ®Google Scholar
• Seto N, Morita H, Hori Y, Yoneta T. The important role of zinc on wound healing of gastric ulcer: Correlation with insulin like grouth factor-I (IGF-I). Ulcer Res 1998;25:150–3.
   Google Scholar
• Campieri M, Lanfranchi GA, Bazzocci G, Brignola C, Sarti F, Franzin G, et al. Treatment of ulcerative colitis with high dose 5-aminosalicylate acid enema. Lancet 1981;2:270–1.
   PubMed Web of Science ®Google Scholar
• Campieri M, Gionchetti P, Belluzzi A, Brignola C, Tampieri M, Iannone P, et al. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Gut 1991;32:929–31.
   PubMed Web of Science ®Google Scholar
• Pokrotnieks J, Marlicz K, Paradowski L, Margus B, Zaborowski P, Grieinwald R, et al. Efficacy and tolerability of mesalazine foam (salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo controlled study. Aliment pharmacol Ther 2000;14:1191–8.
   PubMed Web of Science ®Google Scholar
• Hamilton I, Pinder IF, Dickinson RJ, Ruddell WS, Dixon MF, Axon AT. A comparison of prednisolone enemas with low-dose oral prednisolone in the treatment of acute distal ulcerative colitis. Dis Colon Rectum 1984;27:701–2.
   PubMed Web of Science ®Google Scholar
• Hanauer SB, Robinson M, Pruitt R, Lazenby AJ, Persson T, Nilsson LG, et al. Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. Gastroenterology 1998;115:525–32.
   PubMed Web of Science ®Google Scholar
• Kishimoto S, Haruma K, Tari A, Sakurai K, Nakano M, Nakagawa Y. Rebamipide,an antiulcer drug, prevents DSS-induced colitis formation in rats. Dig Dis Sci 2000;45:1608–16.
   PubMed Web of Science ®Google Scholar
• Nakashima T, Maeda T, Nagamoto H, Kumakura T, Takai M, Mori T. Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats. Dig Dis Sci 2005;50:S124–31.
   Web of Science ®Google Scholar
• Miyata M, Kasugai K, Ishikawa T, Kakumu S, Onishi M, Mori T. Rebamipide enemas-New effective treatment for patients with corticosteroid dependent or resistant ulcerative colitis. Dig Dis Sci 2005;50:S119–23.
   Web of Science ®Google Scholar
• Makiyama K, Takeshima F, Hamamoto T. Efficacy of rebamipide enemas in active distal ulcerative colitis and proctitis: a prospective study report. Dig Dis Sci 2005;50:S2323–9.
   PubMed Web of Science ®Google Scholar
• Murai R, Kanbe T, Mukoyama T, Shimomura T, Hashiguchi K, Yoshida Y, et al. Effect of rectal administration of rebamipide on dextran sulfate sodium-induced colitis: role of hepatocyte growth factor. Inflamm Res 2007;56:240–5.
   PubMed Web of Science ®Google Scholar
• Furuta R, Ando T, Watanabe O, Maeda O, Ishiguro K, Ina K, et al. Rebamipide enema therapy as a treatment for patients with active distal ulcerative colitis. J Gastroenterol Hepatol 2007;22:261–7.
   PubMed Web of Science ®Google Scholar
• Kono T, Nomura M, Kasai S, Kohgo Y. Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study. Am J Gastroenterol 2001;96:793–7.
   PubMed Web of Science ®Google Scholar
• Noto T, Yamada H, Inui T, Okuyama K, Watanabe A, Kimura I, et al. Therapeutic effects of ecabet sodium, an antiulcer drug, on dextran sodium sulfate-induced ulcerative colitis in rats. Dig Dis Sci 2005;50:922–7.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Yamaguchi T, Yoshida N, Yamamoto H, Kitazumi S, Takahashi S, et al. Effects of Z-103 on TNB-induced colitis in rats. Digestion 1997;58:464–8.
   PubMed Web of Science ®Google Scholar
• Ohkawara T, Taked H, Kato K, Miyashita K, Kato M, Iwanaga T, et al. Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium- induced colitis in mice. Scand J Gastroenterol 2005;40:1321–7.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Okamura S, Kudo T, Masuo T, Mori M. Calcineurin inhibition by polaprezinc inrats with experimentally-induced colitis. Life Sci 2011;88:432–9.
   PubMed Web of Science ®Google Scholar
• Schroeder KW, Remaine WJ, Ilstrup DM. Coasted oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625–9.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Tremaine WJ, Schroeder KW, Batts KP, Lawson GM, Steiner BL, et al. A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis. Gastroenterology 1994;106:1429–35.
   PubMed Web of Science ®Google Scholar
• Matts SGF. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med J 1961;30:393–407.
   PubMedGoogle Scholar
• Takahashi M, Oka S, Takada H, Fukuda K, Kiumi F, Soma R, et al. Comparison of efficacy of gastroprotectants on rat colitis induced by subserosal injection of acetic acid and the role of cyclooxygenase-2. Ulcer Res 2005;32:149–53.
   Google Scholar